ARCHIVES

Kadcyla Extends Median PFS In Open-Label Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists

November 14, 1975

Letter: Medicare Policy May Delay Access to Cancer Drugs

June 13, 2003

NCI Could Fund Some Challenge Grants That Miss NIH Funding, Director Says

June 26, 2009

In Brief: Senate Committee Refuses to Cut NCI 1982 Funds; Linus Pauling to Speak At conference On Vitamins

November 13, 1981

Obey Aide Objects To Criticism Over Earmarking New NCI Positions

August 13, 1976

New Therapeutic Modalities In Testing For Patients With Carcinoid Syndrome

November 28, 2003